222 related articles for article (PubMed ID: 31668985)
1. Radiomic signature: A novel magnetic resonance imaging-based prognostic biomarker in patients with skull base chordoma.
Wei W; Wang K; Liu Z; Tian K; Wang L; Du J; Ma J; Wang S; Li L; Zhao R; Cui L; Wu Z; Tian J
Radiother Oncol; 2019 Dec; 141():239-246. PubMed ID: 31668985
[TBL] [Abstract][Full Text] [Related]
2. Radiomic analysis of multiparametric magnetic resonance imaging for differentiating skull base chordoma and chondrosarcoma.
Li L; Wang K; Ma X; Liu Z; Wang S; Du J; Tian K; Zhou X; Wei W; Sun K; Lin Y; Wu Z; Tian J
Eur J Radiol; 2019 Sep; 118():81-87. PubMed ID: 31439263
[TBL] [Abstract][Full Text] [Related]
3. High expression of survivin independently correlates with tumor progression and mortality in patients with skull base chordomas.
Ma J; Tian K; Du J; Wu Z; Wang L; Zhang J
J Neurosurg; 2019 Jan; 132(1):140-149. PubMed ID: 30641849
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and surgical outcomes of patients with skull base chordoma: a retrospective analysis of 238 patients.
Wang L; Wu Z; Tian K; Wang K; Li D; Ma J; Jia G; Zhang L; Zhang J
J Neurosurg; 2017 Dec; 127(6):1257-1267. PubMed ID: 28059654
[TBL] [Abstract][Full Text] [Related]
5. Skull base chordomas: clinical outcome in a consecutive series of 45 patients with long-term follow-up and evaluation of clinical and biological prognostic factors.
Boari N; Gagliardi F; Cavalli A; Gemma M; Ferrari L; Riva P; Mortini P
J Neurosurg; 2016 Aug; 125(2):450-60. PubMed ID: 26745472
[TBL] [Abstract][Full Text] [Related]
6. MR Imaging Grading System for Skull Base Chordoma.
Tian K; Wang L; Ma J; Wang K; Li D; Du J; Jia G; Wu Z; Zhang J
AJNR Am J Neuroradiol; 2017 Jun; 38(6):1206-1211. PubMed ID: 28428207
[TBL] [Abstract][Full Text] [Related]
7. Multiparametric MRI-Based Radiomic Signature for Preoperative Evaluation of Overall Survival in Intrahepatic Cholangiocarcinoma After Partial Hepatectomy.
Yang Y; Zou X; Zhou W; Yuan G; Hu D; Kuang D; Shen Y; Xie Q; Zhang Q; Hu X; Li Z
J Magn Reson Imaging; 2022 Sep; 56(3):739-751. PubMed ID: 35049076
[TBL] [Abstract][Full Text] [Related]
8. MRI-based radiomic signature as predictive marker for patients with head and neck squamous cell carcinoma.
Yuan Y; Ren J; Shi Y; Tao X
Eur J Radiol; 2019 Aug; 117():193-198. PubMed ID: 31307647
[TBL] [Abstract][Full Text] [Related]
9. The utility of inflammatory biomarkers in predicting overall survival and recurrence in skull base chordoma.
Hoppe M; Gersey ZC; Muthiah N; Abdallah HM; Plute T; Abou-Al-Shaar H; Wang EW; Snyderman CH; Zenonos GA; Gardner PA
Neurosurg Focus; 2024 May; 56(5):E16. PubMed ID: 38691858
[TBL] [Abstract][Full Text] [Related]
10. Quantitative radiomic biomarkers for discrimination between neuromyelitis optica spectrum disorder and multiple sclerosis.
Ma X; Zhang L; Huang D; Lyu J; Fang M; Hu J; Zang Y; Zhang D; Shao H; Ma L; Tian J; Dong D; Lou X
J Magn Reson Imaging; 2019 Apr; 49(4):1113-1121. PubMed ID: 30408268
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Clinical Features and Outcomes of Skull Base Chordoma in Different Age-Groups.
Tian K; Wang L; Wang K; Ma J; Li D; Hao S; Yang Y; Du J; Jia G; Zhang L; Wu Z; Zhang J
World Neurosurg; 2016 Aug; 92():407-417. PubMed ID: 27237421
[TBL] [Abstract][Full Text] [Related]
12. A multi-sequence and habitat-based MRI radiomics signature for preoperative prediction of MGMT promoter methylation in astrocytomas with prognostic implication.
Wei J; Yang G; Hao X; Gu D; Tan Y; Wang X; Dong D; Zhang S; Wang L; Zhang H; Tian J
Eur Radiol; 2019 Feb; 29(2):877-888. PubMed ID: 30039219
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a prognostic nomogram for malignant esophageal fistula based on radiomics and clinical factors.
Zhu C; Ding J; Wang S; Qiu Q; Ji Y; Wang L
Thorac Cancer; 2021 Dec; 12(23):3110-3120. PubMed ID: 34647417
[TBL] [Abstract][Full Text] [Related]
14. Improving survival prediction of high-grade glioma via machine learning techniques based on MRI radiomic, genetic and clinical risk factors.
Tan Y; Mu W; Wang XC; Yang GQ; Gillies RJ; Zhang H
Eur J Radiol; 2019 Nov; 120():108609. PubMed ID: 31606714
[TBL] [Abstract][Full Text] [Related]
15. Predictive Value of Transforming Growth Factor-α and Ki-67 for the Prognosis of Skull Base Chordoma.
Zhang S; Bai J; Li M; Zhai Y; Wang S; Liu Q; Li C; Gui S; Zhang Y
World Neurosurg; 2019 Sep; 129():e199-e206. PubMed ID: 31125781
[TBL] [Abstract][Full Text] [Related]
16. Effect comparisons among treatment measures on progression-free survival in patients with skull base chordomas: a retrospective study of 234 post-surgical cases.
Wang L; Tian K; Ma J; Wang K; Jia G; Wu Z; Zhang L; Zhang J
Acta Neurochir (Wien); 2017 Oct; 159(10):1803-1813. PubMed ID: 28699066
[TBL] [Abstract][Full Text] [Related]
17. Factors for tumor progression in patients with skull base chordoma.
Wang L; Tian K; Wang K; Ma J; Ru X; Du J; Jia G; Zhang L; Wu Z; Zhang J
Cancer Med; 2016 Sep; 5(9):2368-77. PubMed ID: 27546605
[TBL] [Abstract][Full Text] [Related]
18. Factors for Overall Survival in Patients with Skull Base Chordoma: A Retrospective Analysis of 225 Patients.
Tian K; Zhang H; Ma J; Wang K; Ru X; Du J; Jia G; Zhang L; Wu Z; Zhang J; Wang L
World Neurosurg; 2017 Jan; 97():39-48. PubMed ID: 27671886
[TBL] [Abstract][Full Text] [Related]
19. Revisitation of imaging features of skull base chondrosarcoma in comparison to chordoma.
Hasegawa H; Shin M; Niwa R; Koizumi S; Yoshimoto S; Shono N; Shinya Y; Takami H; Tanaka S; Umekawa M; Amemiya S; Kin T; Saito N
J Neurooncol; 2022 Sep; 159(3):581-590. PubMed ID: 35882753
[TBL] [Abstract][Full Text] [Related]
20. Analysis of clinical factors and PDGFR-β in predicting prognosis of patients with clival chordoma.
Zhai Y; Bai J; Wang S; Gao H; Li M; Li C; Gui S; Zhang Y
J Neurosurg; 2018 Dec; 129(6):1429-1437. PubMed ID: 29303447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
